307 related articles for article (PubMed ID: 10030545)
1. Postantibiotic effects of rifampin, amikacin, clarithromycin and ethambutol used alone or in various two-, three- and four-drug combinations against Mycobacterium avium.
Horgen L; Legrand E; Rastogi N
FEMS Immunol Med Microbiol; 1999 Jan; 23(1):37-44. PubMed ID: 10030545
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.
Ellis LC; Benson CA; Koenig GI; Trenholme GM
Antimicrob Agents Chemother; 1995 Dec; 39(12):2803-6. PubMed ID: 8593025
[TBL] [Abstract][Full Text] [Related]
3. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
4. Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
Horgen L; Legrand E; Rastogi N
Res Microbiol; 1997 Nov; 148(8):673-81. PubMed ID: 9765852
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Fuursted K
J Antimicrob Chemother; 1997 Jul; 40(1):33-8. PubMed ID: 9249202
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
7. Activity of seven antimicrobial agents, alone and in combination, against AIDS-associated isolates of Mycobacterium avium complex.
Piersimoni C; Tortoli E; Mascellino MT; Passerini Tosi C; Sbaraglia G; Mandler F; Bistoni F; Bornigia S; De Sio G; Goglio A
J Antimicrob Chemother; 1995 Sep; 36(3):497-502. PubMed ID: 8830013
[TBL] [Abstract][Full Text] [Related]
8. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium avium.
Yajko DM; Sanders CA; Madej JJ; Cawthon VL; Hadley WK
Antimicrob Agents Chemother; 1996 Mar; 40(3):743-9. PubMed ID: 8851604
[TBL] [Abstract][Full Text] [Related]
10. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
Fattorini L; Li B; Piersimoni C; Tortoli E; Xiao Y; Santoro C; Ricci ML; Orefici G
Antimicrob Agents Chemother; 1995 Mar; 39(3):680-5. PubMed ID: 7793873
[TBL] [Abstract][Full Text] [Related]
11. Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.
Zhanel GG; Saunders MH; Wolfe JN; Hoban DJ; Karlowsky JA; Kabani AM
Antimicrob Agents Chemother; 1998 Jan; 42(1):184-7. PubMed ID: 9449284
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Rastogi N; Goh KS; Bryskier A; Devallois A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
[TBL] [Abstract][Full Text] [Related]
14. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
[TBL] [Abstract][Full Text] [Related]
15. Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Dubé MP; Torriani FJ; See D; Havlir DV; Kemper CA; Leedom JM; Tilles JG; McCutchan JA; Sattler FR
Clin Infect Dis; 1999 Jan; 28(1):136-8. PubMed ID: 10028084
[TBL] [Abstract][Full Text] [Related]
16. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Parenti DM; Williams PL; Hafner R; Jacobs MR; Hojczyk P; Hooton TM; Barber TW; Simpson G; van der Horst C; Currier J; Powderly WG; Limjoco M; Ellner JJ
AIDS; 1998 Dec; 12(18):2439-46. PubMed ID: 9875582
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Bakker-Woudenberg IA; van Vianen W; van Soolingen D; Verbrugh HA; van Agtmael MA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2387-98. PubMed ID: 15917538
[TBL] [Abstract][Full Text] [Related]
18. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
Rastogi N; Goh KS; Bryskier A
Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
[TBL] [Abstract][Full Text] [Related]
19. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Adachi Y; Tsuyuguchi K; Kobayashi T; Kurahara Y; Yoshida S; Kagawa T; Hayashi S; Suzuki K
J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
